Sanara Medtech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.4% | +4.8% | +8.8% | +7.5% | +21.4% | -10.9% | +10.2% | +1.9% | +4.6% | +0.9% | +1.2% | – | |
| – | +2.1% | +5.7% | +6.3% | -0.8% | +12.9% | +12.4% | -23.4% | +28.3% | +2.3% | -1.3% | -21.1% | – | |
| – | +11.4% | +4.7% | +9.0% | +8.4% | +22.2% | -13.1% | +14.3% | -0.2% | +4.8% | +1.1% | +3.4% | – | |
| – | -34.0% | +45.2% | +4.2% | +37.9% | +77.4% | -53.8% | +12.9% | -18.1% | +97.7% | -62.7% | +52.0% | – | |
| – | +17.7% | -0.9% | +17.1% | +0.2% | +18.0% | -4.4% | +0.5% | -7.8% | +1.0% | +9.0% | +3.3% | – | |
| – | +6.2% | +12.7% | +15.7% | +2.7% | +13.1% | -17.8% | +19.2% | -12.7% | +5.9% | +2.4% | +7.7% | – | |
| – | – | – | – | – | – | – | -103.8% | – | -2.4% | -8.5% | -32.7% | – | |
| – | +52.7% | -7.0% | +141.0% | +44.0% | +39.0% | +2.2% | +36.0% | +1.5% | +0.8% | -1.8% | +0.6% | – | |
| – | – | – | – | – | – | – | – | – | -232.7% | – | -203.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -198.7% | – | |
| – | -1,293.4% | – | – | – | – | +52.1% | -51.3% | +267.8% | -57.3% | +99.7% | -27.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.